Lifecore Biomedical, Inc. De (LFCR) Total Debt (2011 - 2025)

Lifecore Biomedical's Total Debt history runs 15 years deep, the most recent figure standing at $5.8 million for Q2 2025.

• In Q2 2025, Total Debt fell 94.29% year-over-year to $5.8 million; the TTM figure through May 2025 stood at $5.8 million (down 94.29% YoY), while the FY2025 annual figure was $5.8 million, down 94.29% from the prior year.
• Total Debt was $5.8 million for Q2 2025 at Lifecore Biomedical, down from $8.3 million in the prior quarter.
• In the past five years, Total Debt ranged from a high of $193.9 million in Q2 2021 to a low of $5.8 million in Q2 2025.
• Historically, Total Debt has averaged $83.3 million across 5 years, with a median of $97.6 million in 2022.
• The sharpest annual moves came in 2024 and 2025: Total Debt soared 506.93% in 2024, then slumped 94.29% in 2025.
• A 5-year view of Total Debt shows it stood at $166.2 million in 2021, then plunged by 40.46% to $99.0 million in 2022, then slumped by 82.16% to $17.7 million in 2023, then sank by 47.46% to $9.3 million in 2024, then plunged by 37.44% to $5.8 million in 2025.
• The last three Total Debt figures came in at $5.8 million (Q2 2025), $8.3 million (Q1 2025), and $9.3 million (Q4 2024), per Business Quant data.